COX6B1

COX6B1 is a nuclear-encoded structural subunit of mitochondrial cytochrome c oxidase (Complex IV) that is essential for the enzyme's assembly and catalytic activity (PMID:24781756, PMID:41419202). Beyond serving as a static structural component, COX6B1 participates in COX2 biogenesis and copper delivery to Complex IV through physical interaction with COX2 and the assembly factor COA6, as established in the yeast ortholog Cox12, where combined loss of Cox12 and Coa6 abolishes Cox2 biogenesis (PMID:26669719). COX6B1 is required for redox-sensitive early assembly steps as well as late-stage stabilization of Complex IV, and partially assembled cIV modules incorporate directly into respiratory chain supercomplexes, consistent with a cooperative assembly model (PMID:41419202); its overexpression increases incorporation of Complex IV into III2IV1/III2IV2 supercomplexes and elevates COX activity, oxygen consumption, and ATP (PMID:25929654). Loss of COX6B1 — through pathogenic missense mutations such as p.R20C or genetic knockout — causes total Complex IV deficiency, and re-expression of wild-type COX6B1 restores COX activity, directly linking the gene to human COX-deficiency disease (PMID:18499082, PMID:24781756, PMID:41419202). In stress models, COX6B1 overexpression preserves mitochondrial integrity, retaining cytochrome c, maintaining membrane potential, and suppressing apoptotic signaling under ischemic conditions (PMID:30311029, PMID:31059068).

1. 2008 Medium

   Established that COX6B1 is an essential structural subunit of Complex IV by showing a disease-associated mutation produces severe COX deficiency compatible with extra-uterine survival.

   Evidence Patient mutation identification with biochemical COX activity assay

   PMID:18499082

   Open questions at the time

   • Single patient/study without complementation rescue
   • Mechanism by which loss causes deficiency not defined
   • Whether defect is assembly versus stability not addressed
2. 2014 High

   Demonstrated functional necessity of COX6B1 for Complex IV activity by showing the p.R20C mutation abolishes COX activity and wild-type cDNA complementation restores it.

   Evidence Enzymatic activity assay plus lentiviral complementation in patient fibroblasts/muscle

   PMID:24781756

   Open questions at the time

   • Does not resolve which assembly step requires COX6B1
   • No direct interaction partners identified
   • Structural basis of the R20C defect unknown
3. 2015 High

   Identified a previously unrecognized role for COX6B1/Cox12 in COX2 biogenesis and copper delivery, moving it beyond a purely structural subunit.

   Evidence Yeast genetic epistasis (cox12Δ/coa6Δ double mutant), Co-IP of Cox12 with Cox2 and Coa6, overexpression rescue

   PMID:26669719

   Open questions at the time

   • Direct copper-delivery role inferred from genetic interaction, not biochemically reconstituted
   • Human COX6B1 interactions inferred from yeast ortholog
   • Stoichiometry and timing of the interaction undefined
4. 2015 Medium

   Showed COX6B1 promotes supercomplex formation and enhances respiration, linking subunit levels to assembly into higher-order respiratory structures.

   Evidence Cox6b1 overexpression in NIH3T3 cells with BN-PAGE, oxygen consumption, COX activity, and ATP measurements

   PMID:25929654

   Open questions at the time

   • Overexpression model without loss-of-function confirmation
   • Single lab
   • Mechanism of supercomplex incorporation not defined
5. 2018 Medium

   Connected COX6B1 to maintenance of mitochondrial integrity under ischemic stress, indicating a cytoprotective function beyond steady-state respiration.

   Evidence COX6B1 overexpression in neonatal rat cardiomyocytes under hypoxia/reoxygenation with mPTP, membrane potential, ROS, cytochrome c, and caspase assays

   PMID:30311029

   Open questions at the time

   • Overexpression only, no knockout rescue
   • Whether protection is direct or secondary to improved respiration unclear
   • Single lab
6. 2019 Medium

   Extended the cytoprotective role of COX6B1 to neurons, showing it limits apoptosis and calcium dysregulation during ischemia/reperfusion.

   Evidence COX6B1 overexpression in primary rat hippocampal neurons under oxygen-glucose deprivation with apoptosis, Ca2+, and BCL-2/BAX assays

   PMID:31059068

   Open questions at the time

   • Overexpression model without endogenous loss-of-function
   • Causal link between respiration and anti-apoptotic effect not dissected
   • Single lab
7. 2022 Medium

   Placed COX6B1 as a downstream effector of miR-30b-3p in lung adenocarcinoma, tying its expression to cancer cell proliferation and invasion.

   Evidence Dual-luciferase reporter, Western blot, EdU/Transwell assays, and rescue experiment in A549 cells

   PMID:36002193

   Open questions at the time

   • Mechanism connecting COX6B1 to proliferation/invasion not defined
   • Single cell line and lab
   • Whether effect depends on respiratory function unknown
8. 2025 High

   Resolved that COX6B1 acts at redox-sensitive early assembly steps as well as late stabilization, and that partial cIV modules feed directly into supercomplexes, refining the assembly model.

   Evidence CRISPR KO human cells with alternative oxidase expression and pathogenic variant complementation, BN-PAGE/SDS-PAGE assembly analysis

   PMID:41419202

   Open questions at the time

   • Molecular nature of the redox-sensitive step not fully defined
   • Structural snapshot of the early assembly intermediate lacking
   • How specific pathogenic variants map to early versus late defects incompletely resolved

• How COX6B1 mechanistically couples copper delivery to COX2 with redox-sensitive early assembly, and whether its cytoprotective and cancer-associated roles are direct consequences of its assembly function, remain open.
• No reconstituted biochemistry of COX6B1-mediated copper handling in human cells
• Cytoprotective and oncogenic phenotypes rest on overexpression models
• No structural model of the early redox-sensitive assembly intermediate